Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Fastest growing supplement companies

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Rexall Sundown and NBTY named among the 100 fastest growing companies in America by Fortune magazine. The report, which appears in the Sept. 28 issue, ranks Rexall Sundown 28th overall and second among Florida-based companies, while NBTY is 41st overall and second among New York-based firms. The rankings were compiled by Zacks Investment Research and are based upon earnings-per-share growth over three years

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

Idorsia’s Novel Hypertension Pill Among Eight New Drugs To Win EMA Nod

AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA

EU Parliament OKs New Rules On Use Of Patient Data In Research

See All
UsernamePublicRestriction

Register

PS088867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By